Author

Jordan Denizeau

Inserm

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 5

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Research Focus:host-pathogen & immune response· 3 Organism:mouse· 3 Assay:bulk RNA-seq· 2 Research Focus:cell type annotation· 2 Research Focus:clustering· 2 Organism:human· 2 Assay:scRNA-seq· 2

Frequent Co-Authors

Christine SedlikiD· 5 shared Eliane PiaggioiD· 5 shared Wilfrid RicheriD· 4 shared Jimena ToselloiD· 3 shared Joshua J. WaterfalliD· 3 shared Mylène BoheciD· 3 shared Rafael Mena‐OsunaiD· 3 shared Sylvain BaulandeiD· 3 shared

Activity by Year

2025-2026 · peak 3/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

5 shared papersImmunology

Christine SedlikORCID

Mutual co-authors in cluster

Author profile →

5 papers

Recent·Most cited

A comprehensive analysis of humanized mouse models for the study of cancer immunotherapies

Philippe De La Rochère, Laure Loumagne, Mélanie Rathaux, Marine Dubois, Jordan Denizeau, Fariba Némati, Sophie Viel, Dario Rocha, Tamara Slavnic, Jayant Thatted, Christine Sedlik, Xuesong Ouyang, Didier Decaudin, Georges A. Azar, Sukhvinder Sidhu, Eliane Piaggio

This study compares two humanized mouse models for cancer immunotherapies, finding differences in immune cell engraftment and tumor response to T-cell-directed therapies.

Frontiers in Immunology · Apr 7, 2026Peer-reviewedImmunology

The differentiation and functional landscape of tumor-resident CD8⁺ T cells shapes immunity and clinical outcomes in clear cell renal cell carcinoma

Sofía Hidalgo, Andrés Hernández‐Oliveras, Jimena Tosello Boari, Javiera Reyes-Alvarez, Sergio Herńandez-Galaz, Catalina Bustamante, Ernesto López, Yoann Missolo-Koussou, Wilfrid Richer, Vincenzo Benedetti, Farides Saavedra, Marco Fraga, Eduardo Roa, Diego A. Figueroa, Christine Sedlik, , Álvaro Lladser

The paper identifies three CD8+ T cell subsets in ccRCC and links their differentiation states to clinical outcomes.

bioRxiv · Mar 15, 2026 · PreprintImmunology

Myeloid reprogramming by poly(I:C) recruits progenitor-exhausted CD8+ T cells and sensitizes rhabdoid tumors to PD-1 blockade

Valeria Sandoval Manríquez, Sofia Cavada-Silva, Kévin Beccaria, Leticia Laura Niborski, Amaury Leruste, Wilfrid Richer, Mathias Vandenbogaert, Zhi‐Yan Han, Christine Sedlik, Jordan Denizeau, Jérémy Mesple, Zoé Fusilier, Laëtitia Lesage, Jérémie D. Goldstein, Yohan Gerber-Ferder, , Eliane Piaggio

This study shows that poly(I:C) reprograms myeloid cells in rhabdoid tumors, enhancing CD8+ T cell infiltration and improving response to PD-1 blockade.

bioRxiv · Dec 29, 2025 · PreprintImmunology

Dual PD-L1/TIGIT blockade induces PNAd+ HEV-like vessels and CD62L+ lymphocyte recruitment, driving rhabdoid tumor rejection

Stéphanie Fitte-Duval, S Silva, Rafael Mena‐Osuna, Owen Hoare, Leticia Laura Niborski, Jordan Denizeau, Laëtitia Lesage, Wilfrid Richer, Christine Sedlik, Kévin Beccaria, Maëva Veyssière, Rachida Bouarich-Bourimi, Jérémie D. Goldstein, Federico Marziali, Jimena Tosello, , Eliane Piaggio

This study shows that combining PD-L1 and TIGIT blockade in a mouse model of rhabdoid tumors leads to tumor regression by promoting immune cell recruitment and vascular changes.

bioRxiv · Dec 17, 2025 · PreprintImmunology

Common origin for effector and regulatory Follicular and Tissue-Adapted CD4+ T cells in Non-Small Cell Lung Cancer

Jimena Tosello, Wilfrid Richer, Yoann Missolo-Koussou, Elisa Bonnin, Sébastien Lemoine, Marco Antônio M. Pretti, Rodrigo Nalio Ramos, Jordan Denizeau, Sylvain Baulande, Mylène Bohec, Sonia Lameiras, Philippe Martin, Rafael Mena‐Osuna, Jérémy Mesple, Wenjie Sun, , Eliane Piaggio

The paper identifies a common origin for effector and regulatory CD4+ T cells in non-small cell lung cancer through single-cell analysis, revealing their plasticity and role in immune responses.

bioRxiv · Sep 17, 2025 · PreprintImmunology